https://blogs.mercola.com:443/sites/vitalvotes/archive/2020/09/16/astra-zeneca-clams-up-on-covid-vaccine-safety-details-alarming-scientists.aspxA patient in the Astra Zeneca COVID-19 vaccine trials experienced a serious neurological reaction, triggering the company to halt its testing while a review of the case was made. CEO Pascal Soriot talked about it in a closed meeting with its investmentenCommunityServer 2008.5 SP1 (Debug Build: 31106.3070)